Lexicon Pharmaceuticals, Inc. (LXRX) Net Income by Year
Lexicon Pharmaceuticals, Inc. reported a net loss of $50.3M in fiscal year 2025. This represents an increase of 74.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $61.1M net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lexicon Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LXRX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$61.1M | -$50.3M+74.9% | -$200.4M-13.1% | -$177.1M-73.7% | -$101.9M-16.2% | -$87.8M-49.8% | -$58.6M-145.0% | $130.1M+208.0% | -$120.5M+2.0% | -$123.0M+6.4% | -$131.4M-2707.5% | -$4.7M+95.3% | -$100.3M+3.7% | -$104.1M+5.5% | -$110.2M+5.2% | -$116.2M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
LXRX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Lexicon Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Lexicon Pharmaceuticals, Inc.'s net income in fiscal year 2025?
Lexicon Pharmaceuticals, Inc. reported a net loss of $50.3M in fiscal year 2025.
How fast is Lexicon Pharmaceuticals, Inc.'s net income growing?
Lexicon Pharmaceuticals, Inc. (LXRX) net income rose by 74.9% year over year, from -$200.4M to -$50.3M in fiscal year 2025.
What is Lexicon Pharmaceuticals, Inc.'s net income over the last twelve months?
Lexicon Pharmaceuticals, Inc. (LXRX) reported a $61.1M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Lexicon Pharmaceuticals, Inc.'s net income changed over the years?
Across the 15 fiscal years this page covers, Lexicon Pharmaceuticals, Inc. (LXRX) net income went from -$116.2M in fiscal year 2011 to -$50.3M in fiscal year 2025.
What was Lexicon Pharmaceuticals, Inc.'s net income in the most recent quarter?
Lexicon Pharmaceuticals, Inc. (LXRX) reported -$31.8M in net income in Q2 2026. This represents a decrease of 1077.1% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Lexicon Pharmaceuticals, Inc. (LXRX) reported on that line in every period on record.